In another phase II trial, women with breast cancer/precancerous state (ductal carcinoma in situ and atypical ductal hyperplasia) received broccoli sprout extract three times daily for 2–8 weeks with an aim to examine sulforaphane metabolism, HDAC activity, Ki-67 index and apoptosis (NCT00843167). This evidence concerns the gene MKI67 and breast cancer.